Vireo Growth Inc. (VREOF) Financials

VREOF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.3 billion 831.2 million
March 31, 2026 928.8 million 634.7 million
Dec. 31, 2025 817.2 million 509.7 million
Sept. 30, 2025 678.9 million 432.6 million

VREOF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -105.8 million 7.5 million
March 31, 2026 1.1 million 7.0 million
Dec. 31, 2025 8.4 million 3.5 million
Sept. 30, 2025 -21.2 million 4.0 million

VREOF Net Income

No data available :(

VREOF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 104.1 million 288.3 million 163.2 million
March 31, 2026 123.4 million 206.3 million 181.1 million
Dec. 31, 2025 103.3 million 136.2 million 149.9 million
Sept. 30, 2025 98.2 million 139.9 million 46.5 million

VREOF Shares Outstanding

No data available :(

VREOF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 108.2 million - 75.8 million -
March 31, 2026 10.8 million - 37.8 million -
Dec. 31, 2025 10.3 million - 40.6 million -1.2 million
Sept. 30, 2025 14.4 million - 33.7 million 607085

VREOF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 209.3 million 114.0 million
March 31, 2026 106.2 million 46.9 million
Dec. 31, 2025 104.5 million 47.6 million
Sept. 30, 2025 91.7 million 54.3 million

VREOF Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VREOF

Price: $9.03

52 week price:
8.91
22.50

Earnings Per Share: -0.16 USD

P/E Ratio: -2.60

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 363.0 million

Links: